D-0771-2026 Class II Ongoing
FDA drug recall D-0771-2026 was initiated by Golden State Medical Supply Inc. on August 7, 2026 and is designated Class II. Reason for recall: CGMP deviations: tablets with black specks. The recall status is ongoing. Affected quantity: 1200 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- August 26, 2026
- Initiation Date
- August 7, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1200 bottles
Product Description
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Reason for Recall
CGMP deviations: tablets with black specks.
Distribution Pattern
USA Nationwide
Code Information
Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028